12P HER2DX in HER2-positive (HER2+) inflammatory breast cancer (IBC): A correlative analysis from a phase II clinical trial

Autor: Lynce, F., Brasó-Maristany, F., Waks, A.G., Gonzalez, P. Villagrasa, Villacampa, G., Torres, E. Sanfeliu, Galván, P., Brunet, L. Pare, Anderson, L., Perou, C.M., Parker, J., Vivancos, A., Dilullo, M., Simon, S. Pernas, Winer, E.P., Overmoyer, B., Mittendorf, E.A., Prat, A., Tolaney, S.M.
Zdroj: In ESMO Open May 2023 8(1) Supplement 4
Databáze: ScienceDirect